TY - JOUR
T1 - Guidelines and parameters
T2 - Percutaneous sclerotherapy for the treatment of head and neck venous and lymphatic malformations
AU - Heit, Jeremy J.
AU - Do, Huy M.
AU - Prestigiacomo, Charles J.
AU - Delgado-Almandoz, Josser A.
AU - English, Joey
AU - Gandhi, Chirag D.
AU - Albuquerque, Felipe C.
AU - Narayanan, Sandra
AU - Blackham, Kristine A.
AU - Abruzzo, Todd
AU - Albani, Barbara
AU - Fraser, Justin F.
AU - Heck, Don V.
AU - Hussain, M. Shazam
AU - Lee, Seon Kyu
AU - Ansari, Sameer A.
AU - Hetts, Steven W.
AU - Bulsara, Ketan R.
AU - Kelly, Michael
AU - Arthur, Adam S.
AU - Patsalides, Athos
AU - Pride, G. Lee
AU - Powers, Ciaran J.
AU - Alexander, Michael J.
AU - Meyers, Philip M.
AU - Jayaraman, Mahesh V.
N1 - Publisher Copyright:
© 2017, BMJ Publishing Group. All rights reserved.
PY - 2017/6/1
Y1 - 2017/6/1
N2 - Vascular malformations, including VM and LM, of the head and neck are effectively treated by percutaneous sclerotherapy with an excellent clinical response in the majority of patients. Minor complications related to treatment occur in 10-12% of patients treated with detergent sclerosants and in up to 50% of patients when absolute ethanol is used. Major complications are rare in patients being treated with detergent sclerosant agents, but they are more common with the use of absolute ethanol. Future studies should be designed to test the relative effectiveness of different sclerosant agents and techniques. Particular attention should be paid to objective measurement of changes in the volume of treated lesions, improvements in aerodigestive tract and ocular function, and quantified cosmetic improvement in future studies.
AB - Vascular malformations, including VM and LM, of the head and neck are effectively treated by percutaneous sclerotherapy with an excellent clinical response in the majority of patients. Minor complications related to treatment occur in 10-12% of patients treated with detergent sclerosants and in up to 50% of patients when absolute ethanol is used. Major complications are rare in patients being treated with detergent sclerosant agents, but they are more common with the use of absolute ethanol. Future studies should be designed to test the relative effectiveness of different sclerosant agents and techniques. Particular attention should be paid to objective measurement of changes in the volume of treated lesions, improvements in aerodigestive tract and ocular function, and quantified cosmetic improvement in future studies.
KW - Vascular malformation
UR - http://www.scopus.com/inward/record.url?scp=85020136206&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85020136206&partnerID=8YFLogxK
U2 - 10.1136/neurintsurg-2015-012255
DO - 10.1136/neurintsurg-2015-012255
M3 - Review article
C2 - 26801946
AN - SCOPUS:85020136206
SN - 1759-8478
VL - 9
SP - 611
EP - 617
JO - Journal of NeuroInterventional Surgery
JF - Journal of NeuroInterventional Surgery
IS - 6
ER -